Monoclonal antibodies towards tenascin-C (clone 81C6) [65] by Duke University or the BC-2 and BC-4 clones used at Bufalini Hospital (Cesena, Italy) [66, 67] have been developed and are capable of localizing to various GBM in patients. The gene discussed is TNC; the disease is breast cancer.